Supriya Lifescience Limited (NSE:SUPRIYA)
644.45
+6.55 (1.03%)
Nov 12, 2026, 3:29 PM IST
Supriya Lifescience Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Supriya Lifescience stock has a consensus rating of "Hold" and an average price target of ₹765.00. The average 1-year stock price forecast is 18.71% higher than the current stock price, while the lowest is ₹680.00 (+5.52%) and the highest is ₹850.00 (+31.90%).
Price Target: ₹765.00 (+18.71%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Supriya Lifescience stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
9.94B
from 8.28B
Increased by 20.01%
Revenue Next Year
11.92B
from 9.94B
Increased by 19.99%
EPS This Year
17.00
from 26.02
Decreased by -34.67%
EPS Next Year
27.10
from 17.00
Increased by 59.41%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.